CREARE LLC — Department of Defense SBIR Phase II: CBD181-002

CREARE LLC — SBIR Phase II award from Department of Defense.

Amount
$545,486
Agency
Department of Defense · Office for Chemical and Biological Defense
Program / Phase
SBIR · Phase II
Topic
CBD181-002
Solicitation
18.1
NAICS
Place of performance
NH
Period
2020-07-09 → 2022-07-08

Description

The proposed low-SWaP PAPR technology improves the convenience, comfort, and protection level for respirators used in low-threat hazardous environments. Creare’s PAPR technology will be applicable to a variety of respiratory protection needs, including emergency escape, laboratory and field work in low-hazard conditions, and some combat and combat support activities. The PAPR will improve user functionality, task performance, and task duration.